Reactivation of latent tuberculosis through modulation of resuscitation promoting factors by diabetes.

Keywords : ["resuscitation promote factor", "latent tuberculosis", "reactivation", "modulation", "diabetes"]
Author : Fist_Author_Year_PM
41

Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo-controlled trials.

Keywords : ["gender age disease severity body mass index", "subgroup analysis", "subcutaneous tanezumab", "placebocontrolle trial", "diabetes may", "affect response", "week", "treatment", "patient", "osteoarthritis"]
Author : Fist_Author_Year_PM
131

Multi-Targeted Molecular Docking, Pharmacokinetics, and Drug-Likeness Evaluation of Okra-Derived Ligand Abscisic Acid Targeting Signaling Proteins Involved in the Development of Diabetes.

Keywords : ["okraderived ligand abscisic acid target signaling protein involve", "multitargete molecular dock pharmacokinetic", "druglikeness evaluation", "diabetes", "development"]
Author : Fist_Author_Year_PM
34

Fetuin-A secretion from beta-cells leads to accumulation of macrophages in islets, aggravates inflammation and impairs insulin secretion.

Keywords : ["islet aggravate inflammation", "impairs insulin secretion", "fetuina secretion", "betacell lead", "macrophage", "accumulation"]
Author : Fist_Author_Year_PM
39

Brolucizumab-early experience with early extended interval regime in chronic centre involved diabetic macular oedema.

Keywords : ["chronic centre involve diabetic macular oedema", "early extend interval regime", "brolucizumabearly experience"]
Author : Fist_Author_Year_PM
35

TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present).

Keywords : ["patent review", "diabetes treatment", "clinical advancement", "agonist"]
Author : Fist_Author_Year_PM
46

Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus.

Keywords : ["free fatty acid receptor", "type diabetes mellitus", "therapy", "ray", "hope"]
Author : Fist_Author_Year_PM
46

Behavior of hyperreflective spots noted on optical coherence tomography following intravitreal therapy in diabetic macular edema: A systematic review and meta-analysis.

Keywords : ["optical coherence tomography follow intravitreal therapy", "hyperreflective spot note", "diabetic macular edema", "systematic review", "metaanalysis", "behavior"]
Author : Fist_Author_Year_PM
118

Impact of systemic parameters before commencing anti-vascular endothelial growth factor therapy for diabetic macular edema - Pan-Indian survey of retina specialists.

Keywords : ["commence antivascular endothelial growth factor therapy", "diabetic macular edema panindian survey", "systemic parameter", "retina specialist", "impact"]
Author : Fist_Author_Year_PM
34

Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study.

Keywords : ["noncleare vitreous hemorrhage without tractional detachment", "quasirandomized retrospective study", "preoperative bevacizumab", "outcome", "diabetic"]
Author : Fist_Author_Year_PM
90